Veracyte (VCYT) Tops Q1 EPS by 1c

Veracyte (NASDAQ: VCYT) reported Q1 EPS of ($0.24), $0.01 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $16.4 million versus the consensus estimate of $17.69 million.

GUIDANCE:

Veracyte sees FY2017 revenue of $76-84 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.

You May Also Be Interested In

• FTRE (FTRE) Misses Q1 EPS by 23c, provides guidance
• Lucid Diagnostics Inc. (LUCD) Tops Q1 EPS by 4c
• Revelation Biosciences (REVB) Reports Q4 Loss of $2.46